Nephros Announces Third Quarter 2019 Financial Results Conference Call
October 31 2019 - 7:30AM
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial
stage company that develops and sells high performance water
purification products to the medical device and commercial markets,
today announced that it will file its third quarter 2019 financial
results on Wednesday, November 6, 2019 and will host a
conference call that same day at 9:00 AM ET, during which
management will discuss the company's financial results and provide
a general business overview.
Participants may dial into the following number
to access the call: 1-866-652-5200. International callers may use
+1-412-317-6060. Please ask to be joined into the Nephros
conference call. A replay of the call can be accessed until
November 13, 2019 at 1-877-344-7529 or +1-412-317-0088 for
international callers, and entering replay access code: 10136668.
An audio archive of the call will be available shortly after the
call on the Nephros investor relations page at
https://www.nephros.com/investor-relations/.
About Nephros, Inc.
Nephros is a commercial stage company that
develops and sells high performance water purification products to
the medical device and commercial markets. Nephros ultrafilters are
primarily used in hospitals and medical clinics for added
protection in retaining bacteria (e.g., Legionella, Pseudomonas)
and viruses from water, providing barriers that assist in improving
infection control in showers, sinks, and ice machines.
Additionally, Nephros ultrafilters are used by dialysis centers for
assisting in the added removal of endotoxins and other biological
contaminants from the water and bicarbonate concentrate supplied to
hemodialysis machines and patients.
Nephros filters, including AETHERâ„¢ brand
filters, improve the taste and odor of water and reduce biofilm,
bacteria, and scale build-up in downstream equipment. Nephros and
AETHERâ„¢ products are used in the health care, food service,
hospitality, and convenience store markets.
For more information about Nephros, please visit
its website at www.nephros.com.
Contact:Investor Relations
Contacts:
Kirin Smith, PresidentPCG Advisory, Inc.(646)
863-6519ksmith@pcgadvisory.comwww.pcgadvisory.com
Andy Astor, COO & CFONephros, Inc.(201)
345-0824andy@nephros.comwww.nephros.com
Nephros (NASDAQ:NEPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nephros (NASDAQ:NEPH)
Historical Stock Chart
From Sep 2023 to Sep 2024